Bioengineered phytomolecules-capped silver nanoparticles using Carissa carandas leaf extract to embed on to urinary catheter to combat UTI pathogens.
Haajira Beevi Habeeb RahumanRanjithkumar DhandapaniVelmurugan PalanivelSathiamoorthi ThangaveluRagul ParamasivamMuthupandian SaravananPublished in: PloS one (2021)
Rising incidents of urinary tract infections (UTIs) among catheterized patients is a noteworthy problem in clinic due to their colonization of uropathogens on abiotic surfaces. Herein, we have examined the surface modification of urinary catheter by embedding with eco-friendly synthesized phytomolecules-capped silver nanoparticles (AgNPs) to prevent the invasion and colonization of uropathogens. The preliminary confirmation of AgNPs production in the reaction mixture was witnessed by the colour change and surface resonance plasmon (SRP) band at 410nm by UV-visible spectroscopy. The morphology, size, crystalline nature, and elemental composition of attained AgNPs were further confirmed by the transmission electron microscopy (TEM), selected area electron diffraction (SAED), X-ray diffraction (XRD) technique, Scanning electron microscopy (SEM) and energy dispersive spectroscopy (EDS). The functional groups of AgNPs with stabilization/capped phytochemicals were detected by Fourier-transform infrared spectroscopy (FTIR). Further, antibiofilm activity of synthesized AgNPs against biofilm producers such as Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa were determined by viability assays and micrographically. AgNPs coated and coating-free catheters performed to treat with bacterial pathogen to analyze the mat formation and disruption of biofilm formation. Synergistic effect of AgNPs with antibiotic reveals that it can enhance the activity of antibiotics, AgNPs coated catheter revealed that, it has potential antimicrobial activity and antibiofilm activity. In summary, C. carandas leaf extract mediated synthesized AgNPs will open a new avenue and a promising template to embed on urinary catheter to control clinical pathogens.
Keyphrases
- silver nanoparticles
- electron microscopy
- biofilm formation
- pseudomonas aeruginosa
- staphylococcus aureus
- urinary tract infection
- escherichia coli
- candida albicans
- high resolution
- cystic fibrosis
- ejection fraction
- newly diagnosed
- mass spectrometry
- cancer therapy
- gram negative
- acinetobacter baumannii
- multidrug resistant
- ultrasound guided
- prognostic factors
- antimicrobial resistance
- high throughput
- transcription factor
- photodynamic therapy
- aqueous solution
- magnetic resonance imaging